Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1- antichymotrypsin in Alzheimer's disease and vascular dementia

Dementia and Geriatric Cognitive Disorders

Volumn 11, Issue 5, 2000, Pages 239-244

  Martin, T Rodriguez ^a   Calella, A M ^a   Silva, S ^a   Munna, E ^a   Modena, P ^a   Chiesa, R ^a   Terrevazzi, S ^d   Ruggieri, R M ^d   Palermo, R ^d   Piccoli, F ^d   Confalonieri, R ^b   Tiraboschi, P ^d   Fragiacomo, C ^d   Quadri, P ^c   Lucca, U ^a   Forloni, Gianluigi ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Istituto Pio Albergo Trivulzio   (Italy)

^c Osp Regionale della Beata Vergine   (Italy)

^d NONE

Author keywords

Alzheimer's disease; Apolipoprotein E; Intronic polymorphism; Presenilin 1; Vascular dementia; 1 Antichymotrypsin; Amyloid

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E; PRESENILIN 1;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL;

EID: 0033844315     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017245     Document Type: Article

References (27)

1. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in alte onset families. Science 1993;261:921-923.
2. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Riseh N, van Duijn CM: Effects of age, sex and ethnicity on the association between apolipoprotein genotype and Alzheimer disease. JAMA 1997;278:1349-1356.
3. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R. Thai LJ: The apolipoprotein E ε4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996;47:190-196.
4. Puttfarcken PS, Manelli AM, Falduto MT, Getz GS, LaDu MJ: Effect of apolinoprotein E on neurite outgrowth and β-amyloid-induced toxicity in developing rat primary hippocampal cultures. J Neurochem 1997;68:760-769.
5. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong LM, Jakes R, Alberts MJ, Gilbert JR, Man SH, Hulette C, Einstein G, Schmechel DE, Pericak-Vance MA, Roses AD: Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1997;125:163-171.
6. Poirier J, Delisle MC, Quirion R, et al: Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Neurobiology 1995;92:12260-12264.
7. Frisoni GB, Calabresi L, Geroldi C, Bianchetti A, D'Acquarica AL, Govoni S, Sirtori CR, Trabucchi M, Franceschini G: Apolipoprotein E ε4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-242.
8. Noguchi S, Marukami K, Yamada N: Apolipoprotein genotype and Alzheimer's disease. Lancet 1993;342:737.
9. Lemere C, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, Yamaguchi H, Ruiz A, Martinez A, Madrigal L, Hincapie L, Arango JC, Anthony DC, Koo EH, Goate AM, Selkoc DJ, Arango JC: The E280A presenilin 1 Alzheimer mutation produces increased Aβ 42 deposition and severe cerebellar pathology. Nat Med 1996;2:1146-1150.
10. Wragg M, Hutton M, Talbat C: Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 1996;347:509-512.
11. 1-antichymotrypsin polymorphism. Nat Genet 1995;10:486-488.
12. 1-antichymotrypsin in Alzheimer disease. Genomics 1996;33:53-56.
13. 1-antichymotrypsin) with Alzheimer's disease. Ann Neurol 1998;44:387-390.
14. American Psychiatric Association: Diangostic and Statistical Manual of Mental Disorders, ed 3 (DSM-III-R). Washington, American Psychiatric Association, 1987, pp 97-163.
15. McKhan G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
16. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A: Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488.
17. Yamada M, Itoh Y, Sucmatsu N, Otomo E, Matsushita M: Apolipoprotein E genotype in elderly nondemented subjects without senile changes in the brain. Ann Neurol 1996;40:243-245.
18. Beffert U, Danik M, Krzywkowski P, Ramassamy C, Berrada F, Poirier J: The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease. Brain Res Rev 1998;27:119-142.
19. Tolar M, Keller JN, Than S, Mattson MP, Marques MA, Crutcher KA: Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J Neurosci 1999;19:7100-7110.
20. Gomez-Isla T, West HE, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA. Hyman BT: Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol 1996;39:62-70.
21. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinisto L, Halonen P, Kontula K: Apolipoprotein E, dementia and cortical deposition of β-amyloid protein. N Engl J Med 1995;333:1242-1247.
22. Mahley RW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
23. Victoroff J, Mack WJ, Lyness SA, Chui HC: Multicenter clinicopathological correlation in dementia. Am J Psychiatry 1993;152:1476-1484.
24. Talbot C, Lendon C, Craddock N, Shears S, Morris J, Goate A: Protection against Alzheimer's disease with ApoE ε2. Lancet 1994;343: 1432-1433.
25. Tysoe C, Whittaker J, Cairns N, Atkinson PF, Harrington CR, Xuereb J, Wilcock J, Rubinsztein DC: Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late onset Alzheimer's disease. Neurosci Lett 1997; 222:68-69.
26. Mann DM, Pickering-Brown SM, Bayatti NN, Wright AE, Owen F, Iwatsubo T, Saido TC: An intronic polymorphism in the presenilin-1 gene does not influence the amount or molecular form of the amyloid β protein deposited in Alzheimer's disease. Neursci Lett 1997;222:57-60.
27. Abraham CR, Shirahama T, Potter H: Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's. Cell 1988;52:487-501.